-
-
-
-
-
-
-
Atossa publishes trial data showing endoxifen reduces breast density
-
-
-
-
-
-
-
Atossa gets FDA rare pediatric disease status for DMD drug candidate
-
-
-
-
-
-
-
Atossa Genetics (ATOS) Misses Q3 EPS by 1c
-
-
-
-
-
-
-
NioCorp and Atossa Therapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
-
-
-
-
-
-
Atossa Therapeutics and Ainos Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
-
-
-
-
-
-
-
Atossa Therapeutics (ATOS) Issues Letter to Shareholders
-
-
-
-
-
-
-
Atossa Therapeutics (ATOS) Granted Additional Patent Protection for Endoxifen
-
481,355 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


